Send me a link:

*Text messaging rates may apply.

 Dow Down 0.02% Nasdaq Down 0.04%

Ligand Pharmaceuticals Incorporated (LGND)

-NasdaqGM
51.08 Down 0.57(1.10%) 4:00PM EDT
|After Hours : 51.65 Up 0.57 (1.12%) 5:38PM EDT - Nasdaq Real Time Price
Prev Close:51.65
Open:52.00
Bid:50.01 x 100
Ask:52.99 x 100
1y Target Est:83.80
Beta:0.95
Earnings Date:Jul 28 - Aug 1 (Est.)
Day's Range:50.57 - 52.07
52wk Range:36.82 - 80.42
Volume:242,192
Avg Vol (3m):305,589
Market Cap:1.06B
P/E (ttm):87.62
EPS (ttm):0.58
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for LGND

Comparison

Symbol% ChgMkt Cap
LGNDDown 1.10%1.06B
LLYUp 0.19%69.05B
MRKUp 0.17%170.11B
RHHBYUp 1.14%252.94B

Key Statistics

Forward P/E (1 yr):21.11
P/S (ttm):20.09
Ex-Dividend Date:02-Jul-10

Analysts

Annual EPS Est (Dec-14) :1.44
Quarterly EPS Est (Jun-14) :0.14
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.19

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Ligand Pharmaceuticals Incorporated, a biotechnology company, acquires and develops royalty revenue generating assets in the United States. Its late-stage development programs include Promacta, an oral thrombopoietin receptor agonist therapy for t... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback